Company Profile

Cash Flow

BETA DRUGS LTD.

NSE : BETABSE : ISIN CODE : INE351Y01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE0.000 (0 %)

PREV CLOSE ( ) NA

OPEN PRICE ( ) 0.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 0

TODAY'S LOW / HIGH ( )0.00 0.00

52 WK LOW / HIGH ( )0 0

NSE1605.50-37.4 (-2.28 %)

PREV CLOSE( ) 1642.90

OPEN PRICE ( ) 1651.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2044

TODAY'S LOW / HIGH( ) 1595.00 1665.30

52 WK LOW / HIGH ( )1429.52 2105.67

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

615.38

487.54

410.57

343.01

159.51

Adjustment

-63.67

-42.47

20.20

50.98

65.42

Changes In working Capital

-190.28

-135.77

-196.94

-97.72

-38.93

Cash Flow after changes in Working Capital

361.44

309.30

233.83

296.28

186.00

Cash Flow from Operating Activities

361.44

309.30

233.83

296.28

186.00

Cash Flow from Investing Activities

-357.18

-139.72

-190.69

-217.55

-58.48

Cash Flow from Financing Activities

1179.65

-74.90

-24.74

-9.74

-77.14

Net Cash Inflow / Outflow

1183.91

94.69

18.40

68.99

50.38

Opening Cash & Cash Equivalents

286.33

191.64

173.24

104.25

53.87

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

1470.24

286.33

191.64

173.24

104.25